<DOC>
	<DOCNO>NCT00287235</DOCNO>
	<brief_summary>The primary objective study compare efficacy , safety tolerability Extracorporeal Albumin Dialysis ( ECAD ) use Molecular Adsorbent Recirculating System ( MARS® ) device improve severe HE 2 grade compare Standard Medical Therapy ( SMT ) patient chronic End Stage Liver Disease ( ESLD ) 5 day study period .</brief_summary>
	<brief_title>Efficacy Albumin Dialysis Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System ( MARS )</brief_title>
	<detailed_description>The trial two-group unblinded multicenter clinical trial . Patients randomize receive either SMT SMT plus five day MARS® treatment . The trial design call patient receive baseline hepatic encephalopathy ( HE ) assessment admission , 12-hour interval , give 10 HE measurements treatment use refinement / adaptation Conn West Haven HE Criteria HE score system</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<criteria>1 . Signed write informed consent patient patient 's legally appoint representative 2 . Be least 18 year age ; male female 3 . Have chronic end stage liver disease worsen Hepatic Encephalopathy ( Grades 3,4 ) . 1 . Clinically significant bleed gastrointestinal site within last 24 hour require 2 unit blood maintain stable hemoglobin level 2 . Hemodynamically unstable vasopressor agent blood pressure support ( except renaldosed dopamine ) 3 . On acute chronic hemodialysis continuous renal replacement therapy ( CRRT ) 4 . Pregnancy 5 . Inability obtain informed consent 6 . Uncontrolled sepsis define hemodynamic instability 7 . Postliver transplant 8 . Fulminant hepatic failure 9 . Irreversible brain damage indicate neurologic examination CT image 10 . Endocarditis 11 . Pulmonary edema 12 . Massive aspiration pneumonia secondary Hepatic Encephalopathy 13 . Active alcohol consumption determine positive blood ethanol level enrollment/admission 14 . Acute main portal vein thrombosis patient Hepatocellular Carcinoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Hepatic Encephalopathy</keyword>
	<keyword>End Stage Liver Disease</keyword>
	<keyword>Cirrhosis</keyword>
	<keyword>MARS</keyword>
	<keyword>Albumin Dialysis</keyword>
</DOC>